NVZMY Novozymes A/S Un

OTC
$64.66

Novozymes A/S Un (NVZMY) is expected to report earnings on February 4, 2027, before the market open. The consensus earnings estimate is $0.57 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.4% since its last earnings release on November 5, 2026.

Novozymes A/S Un Missed Consensus Estimates
Thursday, November 5, 2026 · 12:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · Before Open
Earnings Whisper
-
vs $0.57
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $67.07

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Novozymes A/S Un

Novozymes A/S is a biotech company. The Company is engaged in research, development, production and selling enzymes and microorganisms.

Sector

Basic Materials

Industry

Specialty Chemicals

Charts powered in part by Lightweight Charts™ by TradingView.